Latest Developments in Chronic Lymphocytic Leukemia

Hollywood, FL US
March 15, 2014

Target Audience

This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Learning Objectives

Following this program, participants should be able to:

  • Apply key patient and disease factors when selecting optimal therapies for patients with chronic lymphocytic leukemia
  • Choose optimal treatment based on National Comprehensive Cancer Network guidelines for patients with chronic lymphocytic leukemia from currently available options
  • Integrate key data from studies of novel agents into treatment considerations for patients with chronic lymphocytic leukemia
Additional information
Supporters: 

Supported by an educational grant from Genentech; Pharmacyclics, Inc.; and Teva Pharmaceuticals.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
03/15/2014
Course expires: 
08/31/2016
Event starts: 
03/15/2014 - 7:00am
Event ends: 
03/15/2014 - 8:00am
Cost:
$0.00
The Westin Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States

Susan M. O’Brien, MD
The University of Texas MD Anderson Cancer Center

John C. Byrd, MD
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
03/15/2014
Course expires: 
08/31/2016

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing